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Antibiotics are commonly used as the first line of defense in the treatment of infectious diseases. However, the rise of 
antimicrobial resistance (AMR) is rendering many antibiotics less effective. Consequently, effective non-antibiotic 
antimicrobial strategies are urgently needed to combat AMR. This paper presents a strategy utilizing cold plasma for 
the “on-demand” activation of acetyl donor molecules. The process generates an aqueous-based antimicrobial 
formulation comprising a rich mixture of highly oxidizing molecules: peracetic acid, hydrogen peroxide and other 
reactive oxygen and nitrogen species. The synergistic potent oxidative action between these molecules is shown to be 
highly effective at eradicating common wound pathogenic bacteria (Pseudomonas aeruginosa and Staphylococcus 
aureus) and at inactivating a virus (SARS-CoV-2). 
 
Antimicrobials are the most widely used therapeutic drugs worldwide. They have 
revolutionised medicine, farming and agriculture, and veterinary care, and are used in many other 
industries including commercial paint formulations. However, their overuse, particularly in the 
case of antibiotics, has rendered them less effective through the rise of antimicrobial resistance 
(AMR)1. By 2050, AMR is forecasted to cause 10M deaths per annum resulting in a potential 
US$100 trillion shock to the global economy2. Consequently, there is a need for “on demand” 
antibiotic-free solutions for microbial eradication to eliminate the growing problem of AMR in 
healthcare and in our environment. 
                                                          
† Equal co-first authors 




This study describes an antibiotic-free strategy utilising the cold plasma activation of acetyl 
donor antimicrobial precursors. The process generates a potent antimicrobial water-based 
disinfectant (Figure 1). Cold plasma is a low-temperature (e.g. human tissue tolerable) 
electrically-generated partially ionised glow-discharge. When operated into air, cold plasma 
activates the surrounding oxygen, nitrogen and water vapor molecules, generating reactive oxygen 
and nitrogen species (RONS)3–7. These RONS can oxidise molecules and cells which is potentially 
useful for a broad range of applications including water purification, sterilization and 
decontamination of pathogenic microorganisms8. Some of these RONS have a high Henry’s law 
constant such as hydrogen peroxide (H2O2) = 1.92 x 106 and peroxynitrous acid (ONOOH) = 4.8 
x 106 allowing for them to be easily solubilised when delivered by cold plasma into aqueous 
solutions (e.g. water)9. In combination, H2O2 and ONOOH can kill microorganisms through 
oxidative stress, exacerbated at low pH10–12. However, many microorganisms have efficient 
antioxidant defence mechanisms that reduce the antimicrobial efficacy of cold plasma, including 
certain pathogenic bacteria which can release catalase – an antioxidant enzyme that neutralises 
H2O213. To mitigate this likely problem, we investigated the use of two antimicrobial precursor 
acetyl donors, tetraacetylethlynediamine (TAED) and pentaacetate glucose (PAG), to amplify the 
antimicrobial effects of cold plasma. TAED and PAG and their by-products are readily 
biodegradable and are non-toxic if used at low concentrations and can be manufactured using green 
Figure 1: Pictorial overview of the cold plasma activation of an acetyl donor from TAED 





chemistry14–16. Plasma generated H2O2 reacts with the acetyl donors of TAED and PAG to produce 
peracetic acid (PAA) which acts in synergy with H2O2 and other plasma generated RONS, 
providing a potent broad-spectrum antimicrobial solution (Figure 1). PAA at the low 
concentration used in this study, has been shown to be non-toxic in an animal model15. Further, 
PAA does not easily give rise to AMR15 and is used in many industrial applications including food 
decontamination17, wastewater treatment18, hospital waste sterilisation19 and medical instrument 
disinfection20.  An advantage of PAA for these applications is that it does not leave harmful 
residues as it quickly decomposes to acetic acid, oxygen and water. 
The cold plasma jet used for these experiments consisted of an internal stainless steel pin 
high voltage (HV) electrode sealed inside a quartz tube (inner diameter (ID) = 1.5 mm, outer 
diameter (OD) = 3 mm). Two cylindrical ground electrodes made up of copper were placed at 
positions of 56 mm and 110 mm below the tip of the HV electrode (Figure 2(a)). The first ground 
electrode helped to reduce the breakdown voltage while the second ground electrode served to 
increase the length of the plasma jet.  The tube length of 164 mm below the HV electrode was 
designed to maximize the production of H2O221.  Plasma was ignited by purging Ar gas at 1 
standard litres per minute through the tube and supplying 2.38 kV rms voltage at 23.5 kHz to the 
HV electrode producing a dissipated power of 2.71 W (Figure 2(b), also see Supplementary 
Figure 2: (a) Setup of the cold plasma jet assembly, (b) its current-voltage 




Information S1). Under the prescribed conditions, a plasma jet extends out of the tube to a distance 
of ~14 mm (Figure 2(a)) with an optical emission typical of highly reactive species that form 
RONS through downstream reactions (Figure 2(c) and Supplementary material S2). The average 
gas temperature (Tg) of the plasma jet (measured with an infrared thermometer, Fluke 62 Max) 
was found to be cool at 310.5 ± 3.5 K at 4 mm position outside of the tube’s orifice (i.e. at the 
same position as the liquid targets). Optical emission spectra shown in Figure 2(c) was used to 
estimate the electron temperature (Te) and vibrational temperature (Tv) of the plasma jet. Te was 
calculated using collisional-radiative model22 while Tv was derived from the Boltzmann plot by 
analyzing the spectral bands of the nitrogen second positive system23. The values of Te and Tv for 
the plasma jet were found to be 0.73 eV and 2323 K, respectively. A high value of electron 
temperature as compared to relatively lower values of ion and neutral gas temperature (i.e. 
Te>>Tv>>Tg) verifies the non-thermal characteristics of the plasma jet. A mixture of 2.5 mM 
TAED with 2.5 mM PAG in 350 µL deionised water (DIW) was used as the antimicrobial 
precursor because this blended system was previously shown to produce the optimal antimicrobial 
efficacy compared to the molecules used alone24. The antimicrobial efficacy of the plasma 
activated TAED-PAG (PA-TP) was compared to plasma activated DIW (PA-DIW) produced 
under the same plasma conditions. Statistical analysis was performed using a two-sample student 
t-test of unequal variance considering a p < 0.05 as significant.  
The major longer-lived antibacterial agents in PA-TP are H2O2 and PAA. Figure 3 (and 
Supplementary material S3) show the concentration of H2O2 and PAA in PA-TP were 4.5 mM and 
2.9mM, respectively. PA-DIW had a slightly lower H2O2 concentration at 2.5 mM and contained 
no PAA because of the absence of TAED and PAG. PA-TP was more acidic at pH 2 compared to 
PA-DIW at pH 4. 




Formation of H2O2 in PA-DIW and PA-TP is known to occur through several pathways. This 
mainly occurs through the formation of an intermittent product (hydroxyl radical, •OH) 
through:5,21,22 
(a) collisions with electrons: e- + H2O  H + •OH  + e- 
(b) collisions with metastable atoms / radicals: e- + O2  O(3P) + O(1D) + e-, O(1D)+H2O  
2•OH ; e- + N2  N2(A3Σu+) + e-, N2(A3Σu+) + H2O  •OH +N2+H 
(c) collisions with argon metastables: e- + Ar  Arm + e-, Arm+H2O  Ar + H2O+ + e-; e- + 
H2O+  •OH + H 
(d) plasma initiated ultra-violet (UV) photolysis: UV + H2O  H2O*; UV + H2O*  H+ + OH-
; OH-  •OH + e-. 
•OH radicals formed through (a)-(d) subsequently recombine to form H2O2 as shown in the 
reaction: •OH+•OHH2O2. The plasma generated H2O2 molecules subsequently react  with 
the acetyl donor-containing molecules to form PAA. 
In the next experiments, the oxidising capacity of PA-TP and PA-DIW compared to 
standard H2O2 solutions was tested through their ability to oxidise potassium iodide (KI, 
Supplementary material S3). The principle is based upon the oxidation of KI to produce triiodide 
ions with an absorbance maximum of 350 nm. TAED-PAG alone (i.e. prior to plasma activation) 
produces zero absorbance reading at 350 nm indicating that it does not oxidise KI (due to the 
absence of oxidants). Figure 4 shows that 0.61-10mM H2O2 solutions readily oxidise KI. A 
statistically identical level of KI oxidation was achieved with 2.5-5mM H2O2 (p>0.05), indicating 
that the small differences in the H2O2 concentrations in PA-TP (4.5mM) and PA-DIW (2.9mM) 
Figure 4: Oxidation of KI from varying concentrations of H2O2, 
PA-DIW and PA-TP with and without the presence of catalase. 
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should not be a major contributing factor to their oxidative capacity. A slightly higher level of KI 
oxidation was produced by PA-DIW (absorbance @ 350 nm = 0.5) compared to the equivalent 
2.5mM H2O2 standard solution (absorbance @ 350 nm = 0.37). This result is attributed to other 
RONS in the PA-DIW making a further small contribution to the oxidation of KI. PA-TP produced 
a significantly higher level of oxidised KI (absorbance @ 350 nm = 2.4) compared to PA-DIW (p 
< 0.05) attributed to the synergistic oxidation of KI by PAA, H2O2 and other RONS. 
The presence of 75 mg/mL catalase abolished the oxidative capacity of the standard H2O2 
solutions and PA-DIW (Figure 4). This indicates that H2O2 was the major oxidant in PA-DIW. 
Conversely, catalase did not abrogate the oxidative capacity of PA-TP (absorbance @ 350 nm = 
0.5). This result is attributed to the additional oxidant PAA (in PA-TP) that is not affected by the 
catalase.  
Finally, the antimicrobial property of PA-TP and PA-DIW were assessed (Supplementary 
material S4). First assessment was carried out by examining their bactericidal action against 
common wound pathogens Gram-negative Pseudomonas aeruginosa (P. aeruginosa) and Gram-
positive Staphylococcus aureus (S. aureus) in planktonic state. Optical density (OD) measurement 
of the bacteria broth was used to assess bacterial growth. Figure 5(a) shows that the final OD 
measured in the P. aeruginosa culture following treatment with the PA-DIW was lower compared 
to the untreated bacteria positive control (p<0.05) and the same as the sterile broth negative control 
(p>0.05), indicating that PA-DIW significantly reduced the growth of the bacteria. However, PA-
DIW was not bactericidal against S. aureus (Figure 5(a)), presumably due to its more complex 
Gram-positive membrane structure providing a barrier against the treatment. In comparison, PA-
TP treatments decreased bacterial load for P. aeruginosa and S. aureus to an undetectable level (p 
>0.05 compared to the sterile broth). These results indicate that PA-TP is a more effective 
bactericidal agent compared to PA-DIW. Based on our protocols, the starting culture of 2x106 
CFU/mL used in this assay (Supplementary material S4) would equate to ~109 CFU/mL, 
corresponding to an OD of ~4 for both bacteria. Therefore, we estimate that the results achieved 
with the PA-TP correspond to at least a 106-log up to a maximum of ∼109-log reduction in bacterial 
growth. Similar trends were observed when the virucidal activities of PA-TP and PA-DIW were 
tested against SARS-CoV-2 (Supplementary material S5). Figure 5(b) shows that the PA-DIW 
reduced the viral load by 50%, whereas PA-TP achieved a greater reduction in viral load of >84%. 
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Importantly, neither the DIW nor the TP solutions alone (i.e. without plasma activation) were 
antimicrobial against the bacteria and the virus in Figures 5(a) and 5(b). This shows that the high 
antimicrobial activity of PA-TP is indeed attributed to the unique combination of the cold plasma 
jet treatment with TP, which is activated on-demand upon plasma ignition. The test solutions used 
in Figure 5 were diluted 4-fold (Supplementary material S5) and this was kept constant for both 
bacteria and virus assays. We anticipate that a more concentrate PA-TP solution would yield a 
higher level of virus inactivation.  
Overall, this study demonstrates how the antimicrobial effects of cold plasma can be 
amplified with acetyl donor molecules. The acetyl donor formulation can be configured for on-
demand use either in a liquid formulation as demonstrated in this study, or potentially in a cream 
or gel formulation, or even within a hydrogel wound dressing activated by a small hand-held cold 
plasma device. Major advantages of on-demand PA-TP for these applications include the ability 
to produce stable formulations with a long shelf-life and without the requirement of refrigeration, 
and its multipronged action coupled with on-demand activation prevents prolonged exposure of 
microorganisms to sub-optimal concentrations of the antibacterial agents; all of which are likely 
to help resist the development of AMR in healthcare and in our environment. 
Figure 5: (a) Reduction in growth of P. aeruginosa and S. aureus by PA-DIW and PA-TP. 
Results were compared to untreated DIW and TP solutions. Positive control = Untreated 
bacteria; Negative control = Sterile broth. Following treatment, bacteria were incubated in 
the test solutions for 18 h. (b) Reduction in SARS-CoV-2 viral load by PA-DIW and PA-
TP. Results were compared to untreated DIW and TP solutions and untreated virus as a 
positive control. The asterisk (*) symbols above the bars in 5(a) represent statistical 
significance compared to sterile broth (bacteria) with one symbol p = 0.01-0.05, two 
symbols p = 0.001-0.01 and three symbols p < 0.001. The # above PA-TP in 5(b) represents 




See Supplementary material for measurement and calculation of cold plasma jet dissipated 
power (SI 1), optical emission spectrum from the cold plasma jet (SI 2), measurement of H2O2 and 
PAA after cold plasma activation of DIW/acetyl donors (SI 3), antibacterial assays (SI 4) and 
antiviral assays (SI 5). 
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S1: Measurement and calculation of cold plasma jet dissipated power 
The schematic of the experimental setup showing the locations for measuring voltage and current 
signals is presented in Fig. S1. Plasma was generated by using a commercially available PVM500-
4000 alternating current (AC) power supply1. AC power supply was used in this study as the 
breakdown voltage and energy consumption in the discharge is known to be lower than the direct 
current (DC) discharge2. The gap distance (g) between the end of the quartz tube and target liquid 
was set to 4 mm. Voltage signals were measured using a PINTEK HVP-39 pro high voltage probe 
(Pingtek Electronics Co. Ltd) and current signals were measured using a Pearson current probe 
(Pearson Electronics Inc., model 2877).  Both signals were measured at the high voltage cable (Fig. 
2(b) in manuscript) and were recorded on a Siglent SDS1102CML oscilloscope (Siglent Technologies 
Co. Ltd). The total dissipated power (P) was calculated as3:  
P= 𝑓𝑓 ∫ 𝐼𝐼(𝑡𝑡)𝑉𝑉(𝑡𝑡)𝑑𝑑𝑡𝑡 − − − −−−−−−−−−−−− (𝑆𝑆1) 𝑡𝑡=𝑇𝑇𝑡𝑡=0  
where, I(t) and V(t) represent the instantaneous values of current and voltage at a time ‘t’. The 
frequency (f) of the discharge was 23.5 kHz. Using equation (S1), the total dissipated power was 
calculated to be ~2.71 W. 
S2: Optical emission spectrum from the cold plasma jet 
The technique of optical emission spectroscopy (OES) can be used to identify the excited species 
including the short-lived reactive oxygen / nitrogen species generated during the discharge. Optical 
emission signals were measured at a 3 mm position below the end of the quartz tube and recorded 
using a factory calibrated HR4000-CG-UVNIR spectrometer (Ocean Optics Inc., resolution: 0.47 nm) 
Fig. S1: Schematic of the experimental setup 
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with an optical fibre of diameter 600 µm. The integration time in the spectrometer was set to 70 
milliseconds. The typical OES signal of the Ar discharge is presented in Fig. 2(c) in the manuscript. A 
strong emission from the hydroxyl radical (•OH) occurs at 309 nm. The •OH is a precursor for the 
formation of H2O2. Emissions from excited nitrogen (nitrogen second positive system (N2 SPS) and 
nitrogen first negative system (N2 FNS) occur at several wavelengths (296 nm, 311 nm, 315 nm, 336 
nm, 357 nm, 380 nm, 391 nm, etc.) and are also responsible for the formation of the •OH through 
collision with ambient water molecules4,5. The region from 600 – 900 nm is dominated by excited 
argon species, and they also play a major role in the formation of the •OH. 
S3: Measurement of H2O2 and PAA after plasma activation of DIW/acetyl donors  
The concentration of H2O2 in the plasma activated water / acetyl donor solutions was measured using 
a commercially available o-phenylenediamine (OPD, CAS number: 95-54-5, SigmaAldrich Corporation) 
and horseradish peroxidase (HRP, CAS number: 9003-99-0, SigmaAldrich Corporation) detection 
system. In the presence of HRP, OPD reacts with H2O2 to form 2-3-diaminophenazine with an 
absorbance maximum of 450 nm that can be measured spectrophotometrically. A tablet of OPD was 
dissolved in 10 mL of DIW and 20 µL of 2 mg/mL HRP was added into the solution. A 5 µL volume of 
PA-DIW, PA-TP (or different concentrations of H2O2, CAS number: 7722-84-1, SigmaAldrich) were 
added into wells of a 96-well plate containing 195 µL of the OPD / HRP solution and incubated for 15 
minutes at ambient temperature in the dark. The absorbance values were measured with a plate 
reader (Synergy LX, Biotek) at λ = 450 nm. The absorbance reading is proportional to the concentration 
of H2O2 and the obtained line of best fit [Fig. S2] was used to estimate the H2O2 concentration formed 
in the PA-DIW and PA-TP.   
Measurement of the PAA concentration in the PA-TP was performed using the following reagents: (a) 
potassium iodide (CAS number: 7681-11-0, Sigma Aldrich), (b) catalase (CAS number: 9001-05-02, 
Sigma Aldrich), (c) TAED (CAS number: 10543-57-4, Sigma Aldrich), (d) PAG (CAS number: 604-68-2, 
Sigma Aldrich), and (e) PAA (Product code: 10302633, Fisher Scientific). Any H2O2 present in the PA-
DIW or PA-TP is quenched by catalase and remaining species (mainly PAA in PA-TP) result in the 
Fig. S2: Calibration curve used to measure the concentration of H2O2 in PA-DIW and PA-TP. 
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oxidation of KI at 350 nm. To verify this principle, we first studied the inhibition of different 
concentrations of H2O2 (Fig. 4 in manuscript) with catalase. The H2O2 concentrations used in this 
experiment (0.6 – 10 mM) were within the same H2O2 concentration range present in the PA-DIW or 
PA-TP (Fig. 3 in manuscript). The protocol used to obtain Fig. 4 in the manuscript involved mixing 
different concentrations of H2O2 (volume: 100 µL) in either 100 µL of DIW (without catalase) or with 
catalase (concentration: 75 mg/mL, volume: 100 µL) in an Eppendorf tube. This mixture was incubated 
for 15 minutes at room temperature. Afterwards, 20 µL of the solution was transferred to 180 µL of 
100 mM KI and the solution was incubated for an additional 15 minutes in the dark before measuring 
the absorbance (λ = 350 nm, Synergy LX, Biotek).  
The PAA concentration in the PA-TP was determined using a calibration curve of the PAA induced 
oxidation of KI. PAA in aqueous solution is known to dissociate into acetic acid (CH3COOH) and H2O2. 
It was confirmed that CH3COOH does not contribute to the oxidation of KI in our experiments, and 
that the use of 75mg/mL catalase quenches all H2O2 in the dissociated PAA solution. The calibration 
curve was constructed by first preparing different concentrations of PAA (0.5 mM – 8 mM). The diluted 
PAA solutions (volume: 100 µL) were mixed with catalase (concentration: 75 mg/mL, volume: 100 µL) 
in an Eppendorf tube and incubated for 15 minutes. Afterwards, 20 µL of the liquid from the mixture 
was transferred to 180 µL of 100 mM KI and the solution was incubated for an additional 15 minutes 
before measuring the absorbance at 350 nm. The resulting calibration curve is shown in Fig. S3.  
S4: Antibacterial assays 
Staphylococcus aureus (H560) and Pseudomonas aeruginosa (PAO1) were grown in 10 mL of tryptic 
soy broth (TSB) and Luria-Bertani (LB) broth, respectively, at 37°C for 18 h. The cultures were spun at 
10000 rpm and washed and resuspended in phosphate buffered saline (PBS). 10 mL of overnight 
culture was then added into 10 mL of bacterial broth to make a subculture (2x106 CFU/mL). 100 µL 
volume aliquots of the bacteria subculture were added into wells of a 96-well plate followed by 
addition of 100 µL of the “test” solutions (PA-DIW, PA-TP) (to achieve a 1:2 dilution). Further 1:2 




dilution of the test solutions was carried out using the bacteria subculture solution to achieve a final 
dilution of 1:4. Bacteria were grown statically for 18 h at 37°C. Absorbance was recorded at 600 nm 
which corresponded to solution turbidity that is directly related to the concentration of bacteria. 
Bacterial growth was assessed relative to the negative control sterile broth.  
S5: Antiviral assay 
All experiments using SARS-CoV-2 were performed in a Biosafety Level 3 Facility at The Lancaster 
University. The SARS-CoV-2 was propagated in Vero-E6 cells (African green monkey kidney) 
constitutively expressing human angiotensin-converting enzyme 2 (ACE2) receptors as described by 
Pyke et al6. These cells were maintained in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% heat-inactivated foetal calf serum (FCS), 100U of penicillin and 100g of 
streptomycin per mL and incubation at 37°C with 5% CO2. A plaque assay was used to quantify the 
virus titre from three independent experiments. The “test” solutions were diluted 1:2 (50 μL of PA-
DIW or PA-TP in 50 μL DIW) and mixed with 50 μL of viral inoculum (maintained at a concentration 
of 1×106 PFU/mL) to achieve a final dilution of 1:4 of the test solutions. Afterwards, the solutions 
were incubated at room temperature for 15 minutes. The virus-test solution mixtures were mixed by 
pipetting up and down several times, and titrated using 10-fold serial dilutions (3 replicates of each) 
in 12-well culture plates seeded with confluent monolayers of Vero-E6 cells in FCS-free medium, and 
then incubated for 1 h at 37°C. Afterwards, cells were washed twice with PBS before adding 2X 
modified eagle’s medium (MEM)+4% fetal bovine serum (FBS) containing 2% methylcellulose and 
incubated at 37°C. 72 h hours post infection, the media was removed, and cells were washed with 
PBS. Cells were fixed in 4% paraformaldehyde for 1 h at room temperature. Cells were stained with 
0.3% crystal violet in distilled water to visualise and count the plaques. 
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